Drug Shortage Report for TARO-PREGABALIN
Report ID | 141040 |
Drug Identification Number | 02392860 |
Brand name | TARO-PREGABALIN |
Common or Proper name | PREGABALIN |
Company Name | SUN PHARMA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | PREGABALIN |
Strength(s) | 300MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-06-01 |
Estimated end date | 2021-07-16 |
Actual end date | 2021-06-30 |
Shortage status | Resolved |
Updated date | 2021-07-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2021-06-16 | English | Compare |
v2 | 2021-06-16 | French | Compare |
v3 | 2021-07-13 | English | Compare |
v4 | 2021-07-13 | French | Compare |
Showing 1 to 4 of 4